» Articles » PMID: 28270605

Phosphoproteins in Extracellular Vesicles As Candidate Markers for Breast Cancer

Overview
Specialty Science
Date 2017 Mar 9
PMID 28270605
Citations 179
Authors
Affiliations
Soon will be listed here.
Abstract

The state of protein phosphorylation can be a key determinant of cellular physiology such as early-stage cancer, but the development of phosphoproteins in biofluids for disease diagnosis remains elusive. Here we demonstrate a strategy to isolate and identify phosphoproteins in extracellular vesicles (EVs) from human plasma as potential markers to differentiate disease from healthy states. We identified close to 10,000 unique phosphopeptides in EVs isolated from small volumes of plasma samples. Using label-free quantitative phosphoproteomics, we identified 144 phosphoproteins in plasma EVs that are significantly higher in patients diagnosed with breast cancer compared with healthy controls. Several biomarkers were validated in individual patients using paralleled reaction monitoring for targeted quantitation. This study demonstrates that the development of phosphoproteins in plasma EV as disease biomarkers is highly feasible and may transform cancer screening and monitoring.

Citing Articles

CD47 is a tumor cell-derived exosomal signature and regulates tumor immune microenvironment and immunotherapy responses.

Luan Y, Zhang Y, Li S, Gao C, Ying X, Zhao S Transl Oncol. 2025; 53:102291.

PMID: 39864342 PMC: 11803903. DOI: 10.1016/j.tranon.2025.102291.


A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancer.

Bockorny B, Muthuswamy L, Huang L, Hadisurya M, Maria Lim C, Tsai L Elife. 2024; 12.

PMID: 39693144 PMC: 11655061. DOI: 10.7554/eLife.87369.


Chronic Stress-Induced and Tumor Derived SP1 Exosomes Polarizing IL-1β Neutrophils to Increase Lung Metastasis of Breast Cancer.

Zhang L, Pan J, Wang M, Yang J, Zhu S, Li L Adv Sci (Weinh). 2024; 12(4):e2310266.

PMID: 39630109 PMC: 11789585. DOI: 10.1002/advs.202310266.


Extracellular vesicles in cancers: mechanisms, biomarkers, and therapeutic strategies.

Ma Y, Zhang X, Liu C, Zhao Y MedComm (2020). 2024; 5(12):e70009.

PMID: 39611045 PMC: 11604295. DOI: 10.1002/mco2.70009.


Proteomic profile of the antibody diversity in circulating extracellular vesicles of lung adenocarcinoma.

Huang X, Xiong L, Zhang Y, Peng X, Ba H, Yang P Sci Rep. 2024; 14(1):27953.

PMID: 39543163 PMC: 11564652. DOI: 10.1038/s41598-024-78955-6.


References
1.
Sokolova V, Ludwig A, Hornung S, Rotan O, Horn P, Epple M . Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Colloids Surf B Biointerfaces. 2011; 87(1):146-50. DOI: 10.1016/j.colsurfb.2011.05.013. View

2.
Iliuk A, Liu X, Xue L, Liu X, Tao W . Chemical visualization of phosphoproteomes on membrane. Mol Cell Proteomics. 2012; 11(9):629-39. PMC: 3434771. DOI: 10.1074/mcp.O112.018010. View

3.
Nam S, Chang H, Jung H, Gim Y, Kim N, Grailhe R . A pathway-based approach for identifying biomarkers of tumor progression to trastuzumab-resistant breast cancer. Cancer Lett. 2014; 356(2 Pt B):880-90. DOI: 10.1016/j.canlet.2014.10.038. View

4.
Olsen J, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P . Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell. 2006; 127(3):635-48. DOI: 10.1016/j.cell.2006.09.026. View

5.
Rappsilber J, Mann M, Ishihama Y . Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat Protoc. 2007; 2(8):1896-906. DOI: 10.1038/nprot.2007.261. View